Somatic instability of the DNA sequences encoding the polymorphic polyglutamine tract of the AIB1 gene.
BACKGROUND
AIB1 contains a polymorphic polyglutamine tract (poly Q) that is encoded by a trinucleotide CAG repeat. Previously there have been conflicting results regarding the effect of the poly Q tract length on breast cancer. Since poly Q is not encoded by a perfect CAG repeat, the heterozygous polymorphic alleles need to be resolved, to understand the exact DNA sequences encoding poly Q.


METHODS
Poly Q encoding sequences of AIB1 from 107 DNA samples, including breast cancer cell lines, sporadic primary breast tumours, and blood samples from BRCA1/BRCA2 mutation carriers and the general population, were resolved by PCR/cloning followed by sequencing of each individual clone.


RESULTS
25 distinct poly Q encoding sequence patterns were found. More than two distinct sequence patterns were found in a significantly higher proportion of tumours and cell lines than that of the general population, suggesting somatic instability. A significantly higher proportion of cancer cell lines or primary breast tumours than that of the general population contained rare sequence patterns. The proportion of sporadic breast tumours having at least one allele < or =27 repeats is significantly higher than that in the blood of BRCA1/BRCA2 mutation carrier breast cancer patients or the general population.


CONCLUSIONS
The poly Q encoding DNA sequences are somatically unstable in tumour tissues and cell lines. A missense mutation and a very short glutamine repeat in primary tumours suggests that AIB1 activity may be modulated through poly Q, which in turn plays a role in the cotransactivation of gene expressions in breast cancers.
Dai
P
P
Department of Oncology, Georgetown University Medical Center, Washington, DC 20057, USA.
Wong
L-J C
LJ
D000328:Adult; D000368:Aged; D000483:Alleles; D001943:Breast Neoplasms / Q000235:genetics*; D045744:Cell Line, Tumor; D005260:Female; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D008875:Middle Aged; D056921:Nuclear Receptor Coactivator 3; D010455:Peptides / Q000235:genetics*; D011110:Polymorphism, Genetic; D017422:Sequence Analysis, DNA; D014157:Transcription Factors / Q000235:genetics*; D019680:Trinucleotide Repeat Expansion; D014407:Tumor Cells, Cultured
D010455:Peptides; D014157:Transcription Factors; C097188:polyglutamine; D056921:Nuclear Receptor Coactivator 3